Intensive Hemodialysis, Treatment Complications and Tolerability

Slides:



Advertisements
Similar presentations
What Do I want ??? Sudhakar Venturi ST4.
Advertisements

When Using DOPPS Slides. DOPPS Slide Use Guidelines.
The FREEDOM Study (Impact of Short Daily Hemodialysis on Restless Legs Symptoms and Sleep Disturbances) Source Jaber BL, Schiller B, Burkart JM, et al.
NxStage® HHD Therapy Overview
MANUAL CATHETER ASSOCIATED BLOOD STREAM INFECTION (CABSI) SURVEILLANCE
When Using DOPPS Slides. DOPPS Slide Use Guidelines.
Copland M, Komenda P, Weinhandl ED, McCullough PA, Morfin JA
Commentary on ‘The DOPPS Practice Monitor for US Dialysis Care: Potential Impact of Recent Guidelines and Regulatory Changes on Management of Mineral.
The SPRINT Research Group
McCullough PA, Chan CT, Weinhandl ED, Burkart JM, Bakris GL
A.M. Thompson, T.G. Pickering  Kidney International 
Intensive Hemodialysis, Treatment Complications and Tolerability
Long-Term Follow-Up of Patients Receiving Lung-Volume-Reduction Surgery Versus Medical Therapy for Severe Emphysema by the National Emphysema Treatment.
Intensive Hemodialysis: Applied Clinical Practice
McCullough PA, Chan CT, Weinhandl ED, Burkart JM, Bakris GL
Copland M, Komenda P, Weinhandl ED, McCullough PA, Morfin JA
Volume 62, Issue 3, Pages (September 2002)
Intensive Hemodialysis and Health-related Quality of Life
Intensive Hemodialysis and Health-related Quality of Life
Relative mortality risk associated with quartiles of systolic blood pressure compared with systolic
Hypertension in Dialysis Patients
Systolic Blood Pressure Intervention Trial (SPRINT)
Intensive Hemodialysis and Potential Risks with Increasing Treatment
Fan et al. Am J Nephrol 2017;45:   (DOI: / )
Outcomes with trisodium citrate 30% vs heparin as catheter-locking solution (all catheters) in patients on hemodialysis Variable TSC, n (%) Heparin, n.
Bakris GL, Burkhart JM, Weinhandl ED, McCullough PA, Kraus MA
Bakris GL, Burkhart JM, Weinhandl ED, McCullough PA, Kraus MA
Long-Term Follow-Up of Patients Receiving Lung-Volume-Reduction Surgery Versus Medical Therapy for Severe Emphysema by the National Emphysema Treatment.
Impact of Cognitive Function Change on Mortality in Renal Transplant and End-Stage Renal Disease Patients Sharma et al. Am J Nephrol 2016;44: (DOI: / )
Management of hypertension in patients with chronic kidney disease
Hypertension in Dialysis Patients
Probability of cumulative incidence of ESRD, disease-related death, or death from other cause for the entire cohort. Probability of cumulative incidence.
Volume 63, Issue 1, Pages (January 2003)
A Six-hour Hemodialysis Without a Significant Increase in Dialysis Dose, as Judged by Kt/V, Can Reduce the Dosage of Erythropoietin Department of Kidney.
Intensive Hemodialysis and Potential Risks with Increasing Treatment
Intensive Hemodialysis and Health-Related Quality of Life
The risk of hospitalization and modality failure with home dialysis
Need for better diabetes treatment for improved renal outcome
Chronic graft-versus-host disease
Erratum Regarding “Ultrasound Monitoring to Detect Access Stenosis in Hemodialysis Patients: A Systematic Review” (Am J Kidney Dis. 2008;51(4): ) 
Volume 80, Issue 10, Pages (November 2011)
Volume 63, Issue 3, Pages (March 2003)
Anemia management for hemodialysis patients: Kidney Disease Outcomes Quality Initiative (K/DOQI) guidelines and Dialysis Outcomes and Practice Patterns.
Recasting Kidney Failure as Cardiovascular Disease
Michael Copland, MD, Paul Komenda, MD, Eric D
Volume 77, Issue 7, Pages (April 2010)
Deprescribing Calcium-Based Phosphorus Binders in Dialysis Patients
This Month in AJKD American Journal of Kidney Diseases
Achieving blood pressure targets during dialysis improves control but increases intradialytic hypotension  A. Davenport, C. Cox, R. Thuraisingham  Kidney.
Mortality, Hospitalization, and Technique Failure in Daily Home Hemodialysis and Matched Peritoneal Dialysis Patients: A Matched Cohort Study  Eric D.
Rajiv Saran, MD, MS, Bernard J. Canaud, MD, Thomas A
Interdialytic Weight Gain: Trends, Predictors, and Associated Outcomes in the International Dialysis Outcomes and Practice Patterns Study (DOPPS)  Michelle.
Body size and outcomes on peritoneal dialysis in the United States
Volume 70, Issue 10, Pages (November 2006)
Volume 62, Issue 3, Pages (September 2002)
Peter A. McCullough, MD, MPH, Christopher T. Chan, MD, Eric D
Intensive Hemodialysis and Potential Risks With Increasing Treatment
George L. Bakris, MD, John M. Burkart, MD, Eric D
Incidence of in-hospital mortality rates are lower in rapid correction rate group versus slow correction rate group but not significantly different by.
KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease: 2007 Update of Hemoglobin Target    American.
Volume 75, Issue 5, Pages (March 2009)
Better Management of Volume with Intensive Hemodialysis
American Journal of Kidney Diseases
Commentary on ‘The DOPPS Practice Monitor for US Dialysis Care: Potential Impact of Recent Guidelines and Regulatory Changes on Management of Mineral.
Stavros V. Konstantinides et al. JACC 2017;69:
American Journal of Kidney Diseases
Collecting and using patient and treatment center data to improve care: Adequacy of hemodialysis and end-stage renal disease surveillance1  William M.
American Journal of Kidney Diseases
Álvares et al. Am J Nephrol 2017;45: (DOI: / )
Fistula and Survival Outcomes after Fistula Creation among Predialysis Chronic Kidney Disease Stage 5 Patients Miyamoto et al. Am J Nephrol 2017;45:  
Presentation transcript:

Intensive Hemodialysis, Treatment Complications and Tolerability Morfin JA, Fluck RJ, Weinhandl ED, Kansal S, McCullough PA, Komenda P. Intensive Hemodialysis and Treatment Complications and Tolerability. American Journal of Kidney Diseases, Volume 68, Issue 5, S43 - S50. AdvancingDialysis.org

Many of the most commonly reported symptoms among hemodialysis patients and care partners were identified as being more important than life expectancy.1,2 Symptoms identified as more important included fatigue, drops in blood pressure, and cramping. Chapter 5, Figure 1: Prevalence of commonly reported symptoms in a cohort of 550 hemodialysis patients.2 1Caplin B, Kumar S, Davenport A. Patients’ perspective of haemodialysis-associated symptoms. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc. 2011;26(8):2656-2663. doi:10.1093/ndt/gfq763. 2Urquhart-Secord R, Craig JC, Hemmelgarn B, et al. Patient and Caregiver Priorities for Outcomes in Hemodialysis: An International Nominal Group Technique Study. Am J Kidney Dis Off J Natl Kidney Found. March 2016. doi:10.1053/j.ajkd.2016.02.037. AdvancingDialysis.org

The cumulative incidence of intradialytic hypotension was significantly lower with intensive hemodialysis in both of the FHN Trials compared to conventional hemodialysis.1 Chapter 5, Figure 2: Incidence of levels I, II, and III intradialytic hypotension for intensive versus conventional hemodialysis in the FHN Daily Trial and the FHN Nocturnal Trial.1 Symptoms of intradialytic hypotension were classified into 3 categories: those that led to lowering of the UF rate or reduced blood flow (Level I); those that led to the administration of saline, but not to lowering of the UF rate (Level II); and those that led to both the administration of saline and lowering of the UF rate (Level III). 21% Reduction 67% Reduction 1Kotanko P, Garg AX, Depner T, et al. Effects of frequent hemodialysis on blood pressure: Results from the randomized frequent hemodialysis network trials. Hemodial Int Int Symp Home Hemodial. 2015;19(3):386-401. doi:10.1111/hdi.12255. AdvancingDialysis.org

Each 1-hour increment in post-dialysis recovery time was associated with a 3% and 5% increased risk of hospitalization and death respectively.1 Recovery time was from 2 to 6 hours in 41% of patients, from 7 to 12 hours in 17% of patients, and greater than 12 hours in 10% of patients.1 Table 4: Hazard ratios for mortality by reported recovery time. Dashed bars span one standard deviation above and below the mean. 1.34 Relative Risk 1.17 Relative Risk 0.88 Relative Risk 1Rayner HC, Zepel L, Fuller DS, et al. Recovery time, quality of life, and mortality in hemodialysis patients: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis Off J Natl Kidney Found. 2014;64(1):86-94. doi:10.1053/j.ajkd.2014.01.014. AdvancingDialysis.org

In FREEDOM Study, the percentage of patients with recovery time less than 1 hour increased from 19% at baseline to 65% after 12 months.1 Mean post-dialysis recovery time fell from 7.9 hours at baseline to 1.0 hours at 4 months, and to 1.1 hours at 12 months.1 Chapter 5, Figure 4: Mean post-dialysis recovery time in intention-to-treat and per-protocol cohorts of the FREEDOM study.1 Dashed bars span one standard deviation above and below the mean 1Jaber BL, Lee Y, Collins AJ, et al. Effect of daily hemodialysis on depressive symptoms and postdialysis recovery time: interim report from the FREEDOM (Following Rehabilitation, Economics and Everyday-Dialysis Outcome Measurements) Study. Am J Kidney Dis Off J Natl Kidney Found. 2010;56(3):531-539. doi:10.1053/j.ajkd.2010.04.019. AdvancingDialysis.org